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Introduction: In low income countries, 
ICU places are limited and not all sepsis 
patients will benefit from ICU admission. 
Stratification is an important step to iden-
tify patients who require ICU treatment 
from patients who can be treated on gen-
eral ward setting. Improper stratification 
results in increased length of stay, costs, 
morbidity and mortality. Objective: The 
aim of this study was to stratify the risk 
of mortality in patients with sepsis syn-
drome using age, arterial lactate level and 
SOFA score. Methods: In this prospective 
observational study, 250 patients with 
sepsis were enrolled and followed up un-
til discharge. They were categorized into 2 
groups according to 7-days mortality. Re-
sults: SOFA score (≥5) was the only good 
tool (AUC=0.722) while age (≥65 years) 
(AUC=0.650) and arterial lactate (≥3.25 
mmol/L) (0.690) were fair tools to predict 
7-days mortality. A new score “ALSOFA 
score” (≥10) was an excellent tool for pre-
diction (AUC =0.912, 95%CI: 0.851 to 
0.940, p<0.0001). It showed an excellent 
sensitivity (90.9%) and specificity (85.1%). 
Conclusion: In critically ill patients with 
sepsis syndromes, age, arterial lactate and 
SOFA score are fair tools of stratification. 
No single marker/score can be used alone 
to stratify such patients.
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INTRODUCTION
Sepsis is officially defined as “a dysregu-
lated host response to an infection, caus-
ing life-threatening organ dysfunction”. (1) 
The whole world mortality rates are up to 
40% for sepsis and 70% for septic shock. (2) 
Good primary care, source control, early 
antibiotic and adequate critical care provi-
sion are essential for good prognosis in low 
income countries. (3)
In these low income countries, ICU places 
are limited and not all sepsis patients will 
benefit from ICU admission. Stratification 
is an important step to identify patients 
who require ICU treatment from patients 
who can be treated on general ward setting. 
Improper stratification results in increased 
length of stay, costs, morbidity and mortal-
ity. (4, 5)
There are multiple tools to stratify patients 
with sepsis. They include clinical judge-
ment, scoring systems, clinical judgement, 
or using sepsis categories as defined by the 
Surviving Sepsis Campaign,(5) , which is 
not as accurate as clinical judgement or 
scoring systems. (6)
The most applicable scoring systems are 
the “Predisposition, Infection, Response 
and Organ dysfunction” (PIRO) score (7), 
the “Mortality in Emergency Department 
Sepsis” (MEDS) score (8), the “Mortality 
In Severe Sepsis in the Emergency Depart-
ment” (MISSED) score (9) and the well-
known SOFA (10) and qSOFA scores. (5)
The elderly are always at higher risk for 
sepsis due to multiple comorbidities. In 
older patients, intact skin and other physi-
ologic reflexes that contribute to the physi-
cal defense mechanisms to infections may 
degrade. Also, implanted devices and sur-
gical procedures may contribute to that. 
(11)
Serum lactate level is extensively evalu-
ated. Arterial lactate is not well studied al-
though it is easy to obtain during routine 
ABG analysis with low cost. Arterial and 
serum lactate levels were compared in few 
studies. Recent studies showed the role of 
arterial lactate in early diagnosis of sepsis 
in pediatrics. Adult studies usually advise 
not to mix their values. (12) The aim of this 
study was to stratify the risk of mortality in 
patients with sepsis syndromes using age, 
arterial lactate level and SOFA score.
METHODS
After approval of the Medical Ethics Com-
mittee of Alexandria Faculty of Medicine, 
all adult patients who were admitted to 
the Critical Care Medicine department, 
Alexandria Main University Hospital for 
6 months (from the1st of January 2018 to 
the 30th of May 2018) with the diagnosis of 
sepsis (according to 2016 consensus defi-
nition (Sepsis-3) using quick SOFA) were 
assessed for enrollment. Pregnant, trauma 
and immunocompromised patients (can-
cer or patients on immunosuppressive 
drugs) were excluded.
All enrolled patients were subjected directly 
(at admission) to the followings; complete 
history taking, physical examination, labo-
ratory investigations and complete sepsis 
workup. All enrolled patients received the 
standard treatment for management of 
sepsis. The protocol of treatment was not 
changed during the study time. The prima-
ry outcome was 7-days mortality.
Statistical Methods
Data were fed to the computer and analyzed 
using IBM SPSS software package version 
24.0. Qualitative data were described us-
ing number and percent. Quantitative data 
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were described using range (minimum and 
maximum), mean, standard deviation and 
median. Significance of the obtained re-
sults was judged at the 5% level. Chi-square 
test was used for categorical variables, to 
compare between different groups. Fisher’s 
Exact or Monte Carlo correction for chi-
square was used when more than 20% of 
the cells have expected count less than 5. 
Student t-test was used for normally quan-
titative variables. Mann Whitney test was 
used for abnormally quantitative variables.
RESULTS
In this prospective observational study, 
250 patients were enrolled. Then, they 
were categorized into 2 groups according 
to the primary endpoint “7-days mortal-
ity”. Seventy-seven patients (30.8%) were 
died (non-survivors group) and another 
173 patients (69.2%) were survived (survi-
vors group).
Regarding baseline characteristics, the 
percentages of males (52.8%) and females 
(47.2%) were comparable. Pneumonia was 
the most common suspected source of sep-
sis (42%). Mean age was 63.37 years. Non-
survivors showed significantly higher mean 
age (69) than survivors (60.86) (p<0.001). 
Non-survivors showed significantly higher 
SOFA score (7.96) than survivors (5.73) 
(p<0.001). The median of arterial lactate of 
all patients was 4 mmol/L. Non-survivors 
were presented with significantly higher 
median of arterial lactate (5.0) than survi-
vors (3.2) (p<0.001). (Table 1)
Overall median ICU LOS was 6 days. Pa-
tients with septic shock showed compara-

































































































SOFA score 6.42 ± 2.852 5.73 ± 2.554 7.96 ± 2.895 <0.001*

































































SBP (mmHg) 73.68 ±31.42 82.66 ±27.59 53.51 ±30.25 <0.001*
DBP (mmHg) 43.98 ± 22.0 50.20 ±20.10 30.0 ±19.76 <0.001*
HR (beats/min) 114.1 ± 20.39 110.8 ±20.86 121.7 ± 17.14 <0.001*
Temp. (ºC) 38.11 ±0.940 38.22 ±0.911 37.87 ±0.969 0.036*
RR (breath/min) 26.96 ± 7.221 25.88 ± 6.42 29.38 ± 8.30 0.001*
WBCs× 109/L 16.7 ± 9.08 16.18 ± 8.47 17.9 ± 10.25 0.207
CRP (mg/L) 109.86 ±62.54 99.43 ±55.91 133.3 ±70.27 <0.001*
Urea (mg/dL) 104.48 ±77.57 95.98 ±74.08 123.60 ±82.21 0.001*
S.Cr (mg/dL) 2.46 ±2.29 2.35 ± 2.43 2.71 ±1.94 0.003*
24h-UOP (mL/hr) 39.95 ±26.63 44.26 ± 27.47 30.26 ±21.85 <0.001*
GCS 12.42 ±2.377 12.69 ±2.393 11.82 ±2.240 0.001*
Lactate (mmol/L) 4.76 ±2.892 4.18 ±2.692 4.76 ±2.924 <0.001*
COPD: chronic obstructive pulmonary disease, UTI: urinary tract infection, DFI: Diabetic Foot Infection, SBP: Spontaneous Bacterial 
Peritonitis, CRBSI: Catheter-Related Blood Stream Infection. Abdomen sources includes perforated gut and cholangitis. SBP: Systolic 
Blood Pressure, DBP: Diastolic Blood Pressure, HR: Heart Rate, RR: Respiratory rate, Temp: surface body Temperature. S.Cr: Serum 
Creatinine, UOP: Urine Output, GCS: Glasgow Coma Scale. *p is significant when p≤ 0.05
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ble median of LOS (5 days) with patients 
with sepsis (8) (p=0.081). Overall 28-days 
mortality rate was 59.2%. Patients with 
septic shock showed comparable mortality 
(66.7%) with patients with sepsis (55.2%) 
(p=0.105).
After plotting the receiver operating char-
acteristics (ROC) curve for the study 
stratification tools to predict 7-days mor-
tality of all patients (Table 2) (Figure 
1), SOFA score (≥5) was the only good 
tool (AUC=0.722) while age (≥65 years) 
(AUC=0.650) and arterial lactate (≥3.25 
mmol/L) (0.690) were fair tools to predict 
7-days mortality. A new score was im-
plemented using these 3 tools. This score 
ranges from 3 to 15 points. It was arbitrar-
ily mentioned as “ALSOFA score: Age, Lac-
tate and SOFA score”. It was calculated for 
all enrolled patients. (Table 3)
ALSOFA score (≥10) was an excellent tool 
to predict 7-days mortality (AUC=0.912). 
After logistic regression analysis, as ALSO-
FA score increases by one point the odds 
ratio (OR) of 7-days mortality increases by 
2.191 (68.66% increased risk) (p<0.0001). 
(Table 4) (Figure 2)
DISCUSSION
In this study, age ≥65 years was a fair tool 
to predict 7-days mortality (AUC= 0.650, 
95% CI: 0.578 to 0.721, p<0.0001). De 
Groot et al., investigated whether the prog-
nostic utility of the most common severity 
scores were appropriate for risk stratifica-
tion of older (≥70 years) septic patients 
(≥70 years). In-hospital mortality was 
9.5% (95%CI: 7.4 to 11.5) in older patients, 
and 4.6% (95%CI: 3.6 to 5.7) in younger 
patients. In older patients, disease severity 
scores were associated poorly with mortal-
ity (AUC= 0.56 to 0.64). (13)
Warmerdam et al., showed that mortal-
ity in patients with infections was 9.2% 
(95%CI: 7.3 to 11.2) in patients ≥70, twice 
as high as the 4.6% (3.6-5.6) in patients <70 
years. (14) Ginde et al., showed that older 
adults (≥65 years) with severe sepsis, com-
pared with younger adults, had modestly 
higher rate of mortality (24% vs 16%). (15)
Yang et al., showed that age (OR, 8.46; aged 
85 years and older versus aged 18-54 years 
old) was significant and independent pre-
dictor of hospital mortality. (16) Martin et 
al., showed that age was an independent 
predictor of mortality in an adjusted multi-
Table 2. Agreement (sensitivity, specificity) of study stratification tools to predict 7-days mortality 
AUC p value 95% C.I Cut off Sensitivity Specificity PPV NPV
LL UL
Age (years) 0.650 <0.0001* 0.578 0.721 ≥65 84.4 37.8 37.6 84.4
Arterial 
lactate(mmol/L)
0.690 <0.0001* 0.617 0.763 ≥3.25 80.5 51.4 42.5 85.6
SOFA Score 0.722 <0.0001* 0.653 0.791 ≥5 83.1 53.8 44.4 87.8
ALSOFA score 0.912 <0.0001* 0.851 0.940 ≥10 90.9 85.1 53.4 94.1
AUC: Area Under Curve, C.I: Confidence Interval, PPV: Positive Predictive Value, NPV: Negative Predictive Value
Table 3. The calculation of ALSOFA score 
Points 1 2 3 4 5
Age (years)  18 to <35 35 to <50 50 to <55 55 to <60 ≥60
Arterial lactate (mmol/L) < 3 3: <4 4: <5 5: <6 ≥6
SOFA Score  < 2 2 - 3 4 - 5 6 - 7 >7
Table 4. ALSOFA score in prediction of mortality
ALSOFA score 7-days mortality 28-days mortality
13 - 15 66 – 90% 87 – 95%
10 – 12 15 – 47% 59 – 80%
  10 < 15% < 59%
p value < 0.0001* < 0.0001*
Exp (β) 2.191 1.667
95%CI 1.827 : 2.627 1.443 : 1.926
Figure 1. Receiver Operating Characteris-
tics (ROC) curve of study stratification 
tools to predict 7-days mortality
Figure 2. The prediction of mortality using 
ALSOFA score
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variable regression (OR, 2.26; 95%CI: 2.17 
to 2.36). Elderly sepsis patients died earlier 
during hospitalization. (17)
In this study, arterial lactate level ≥3.25 
mmol/L was a fair tool to predict 7-days 
mortality (AUC =0.690, 95% CI: 0.617 
to 0.763, p<0.0001). In critical care units, 
lactate is routinely used for risk stratifica-
tion. Whether venous or arterial lactate 
measured on blood gas is interchangeable 
is not known. To our knowledge, no stud-
ies was conducted to stratify sepsis patients 
according to their initial arterial lactate 
levels. But, Paquet et al., showed that both 
methods presented similar performanc-
es for the prediction of poor prognosis 
(AUC= 0.67). (18)
Recently, Theerawit et al., showed that 
arterial and venous lactate levels were 
strongly correlated (r = 0.934, p < 0.0001, 
r2 = .873). (19) Also, Datta et al., showed 
that the mean difference between them 
was 0.4 mmol/L [95%CI: 0.37 to 0.45], with 
95% limits of agreement from -0.4 (95%CI: 
-0.45 to -0.32) to 1.2 (95%CI: 1.14-1.27). 
Also, venous level less than 2 mmol/l was 
predictive of an arterial level less than 
2 mmol/l. (20)
In Diao et al. study, arterial lactate   1.7 
mmol/L was a good tool to predict mor-
tality (AUC= 0.805) with a good sensitivity 
(79.1%). (21)
In this study, SOFA score ≥5 was a good 
tool to predict 7-days mortality (AUC= 
0.722, 95% CI: 0.653 to 0.791, p<0.0001). 
Innocenti et al., showed that SOFA score 
was associated with a moderate prognostic 
stratification ability. (22)
In contrast to these findings, Garcia-Villa-
lba et al., showed that SOFA score was an 
inadequate prognostic tool in patients at 
low risk of organ damage. Results showed 
that other clinical and analytical variables 
are required to improve the prognostic 
utility of SOFA score. (23)
Macdonald et al., (2014) showed that PIRO 
score (AUC=0.86 (95%CI: 0.80 to 0.92)) 
and MEDS (AUC=0.81 (95%CI: 0.74 to 
0.88)) were better predictor of mortality 
than SOFA score (AUC=0.78 (95%CI: 0.71 
to 0.87)) (24)
In this study, the new stratification tool 
was arbitrarily mentioned ALSOFA score. 
ALSOFA score≥10 was an excellent tool 
to predict 7-days mortality (AUC =0.912 
(95%CI: 0.851 to 0.940)) (p<0.0001). 
It showed excellent sensitivity (90.9%), 
specificity (85.1%), PPV (53.4%) and NPV 
(4.1%).
Bewersdorf et al., showed that a new score 
(The SPEED, Sepsis Patient Evaluation in 
the Emergency Department) was a very 
good tool to predict 28-day mortality in 
septic patients (AUC= 0.81 (95%CI: 0.75 
to 0.86)) in the derivation and (AUC=0.81 
(95%CI: 0.73 to 0.90)) in the validation set. 
(25)
LIMITATIONS
This study has some limitations, as small 
sample size and monocentric design. The 
study design is liable for multiple con-
founding factors. The primary outcome is 
7-days all-cause mortality. We acknowl-
edge that these finding cannot be directly 
extrapolated to other health care facilities.
CONCLUSION
In critically ill patients with sepsis syn-
dromes, age, arterial lactate and SOFA 
score are fair tools of stratification. No 
single marker/score can be used alone 
to stratify such patients. Further larger 
studies should be conducted validate new 
scores. Simple, available and cheap mark-
ers should be used in such scores other-
wise scoring systems should not be used as 
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